Last 12 months
Inside the activity.
7 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 21, 2026 Filed Sep 23, 2026 20:30 UTC |
Garner Todd WEVP and CFO
|
GrantStock Options (Right to Buy) · Derivative | 138,632 | $0.00 Strike: $16.61 | $0.00 |
DisclosureSEC source: 0001628280-26-063227 · wk-form4_1790195401.xml · derivative · entry 2 Garner Todd W · CIK 0001726884 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,632 Underlying: Common Stock · 138,632 shares Expires 2036-09-21 F2 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal annual installments beginning on September 21, 2027. Read SEC document |
| September 21, 2026 Filed Sep 23, 2026 20:30 UTC |
Garner Todd WEVP and CFO
|
GrantCommon Stock | 49,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-063227 · wk-form4_1790195401.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,688 F1 · kind: Reflects a grant of restricted stock units that vest in two equal annual installments beginning on September 21, 2027. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 23:02 UTC |
Ligner EmmanuelDirector · President and CEO
|
Tax withholdingCommon Stock | 29,803 | $13.33 | $397,273.99 |
DisclosureSEC source: 0001628280-26-058303 · wk-form4_1787266951.xml · nonDerivative · entry 1 Ligner Emmanuel · CIK 0002082879 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 737,334 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:12 UTC |
Hankamer BrittanyEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 181 | $13.66 | $2,472.46 |
DisclosureSEC source: 0001628280-26-057645 · wk-form4_1787083918.xml · nonDerivative · entry 1 Hankamer Brittany · CIK 0001990909 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,864 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 21:09 UTC |
Eck Steven WSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,385 | $13.78 | $19,085.30 |
DisclosureSEC source: 0001628280-26-052722 · wk-form4_1785877769.xml · nonDerivative · entry 1 Eck Steven W · CIK 0001748813 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,593 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| July 24, 2026 Filed Jul 27, 2026 21:25 UTC |
Sokenu ClaudiusEVP, Chief Legal & Compliance
|
Tax withholdingCommon Stock | 1,201 | $11.44 | $13,739.44 |
DisclosureSEC source: 0001628280-26-049853 · wk-form4_1785187532.xml · nonDerivative · entry 1 Sokenu Claudius · CIK 0001926784 · EVP, Chief Legal & Compliance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,228 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| June 21, 2026 Filed Jun 22, 2026 21:07 UTC |
Walker CoreyPresident, VWR Dist. & Servs.
|
Tax withholdingCommon Stock | 3,010 | $9.58 | $28,835.80 |
DisclosureSEC source: 0001628280-26-044719 · wk-form4_1782162452.xml · nonDerivative · entry 1 Walker Corey · CIK 0001776172 · President, VWR Dist. & Servs. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 384,535 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| May 08, 2026 Filed May 11, 2026 20:39 UTC |
LUCIER GREGORY TDirector
|
PurchaseCommon Stock | 10,000 | $8.32 | $83,200.00 |
DisclosureSEC source: 0001628280-26-033605 · wk-form4_1778531950.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By a Trust Disclosed balance after: 60,000 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.30 to $8.32, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. F3 · balance_after: By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:38 UTC |
MEHRA SANJEEV KDirector
|
GrantCommon Stock | 25,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-033600 · wk-form4_1778531918.xml · nonDerivative · entry 1 MEHRA SANJEEV K · CIK 0001029623 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,376 F1 · kind: Reflects a grant of restricted stock units that vests on May 07, 2027. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:38 UTC |
SUMME GREGORY LDirector
|
GrantCommon Stock | 25,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-033595 · wk-form4_1778531902.xml · nonDerivative · entry 1 SUMME GREGORY L · CIK 0001143422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,381 F1 · kind: Reflects a grant of restricted stock units that vests on May 7, 2027. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:38 UTC |
Makin LouiseDirector
|
GrantCommon Stock | 25,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-033603 · wk-form4_1778531934.xml · nonDerivative · entry 1 Makin Louise · CIK 0002043398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,140 F1 · kind: Reflects a grant of restricted stock units that vests on May 07, 2027. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:39 UTC |
LUCIER GREGORY TDirector
|
GrantCommon Stock | 25,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-033605 · wk-form4_1778531950.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,006 F1 · kind: Reflects a grant of restricted stock units that vests on May 7, 2027. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:38 UTC |
Massaro Joseph RDirector
|
GrantCommon Stock | 25,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-033602 · wk-form4_1778531926.xml · nonDerivative · entry 1 Massaro Joseph R · CIK 0001380017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,408 F1 · kind: Reflects a grant of restricted stock units that vests on May 07, 2027. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:38 UTC |
SEVERINO MICHAELDirector
|
GrantCommon Stock | 25,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-033598 · wk-form4_1778531911.xml · nonDerivative · entry 1 SEVERINO MICHAEL · CIK 0001609447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,821 F1 · kind: Reflects a grant of restricted stock units that vests on May 07, 2027. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:39 UTC |
Murthy MalaDirector
|
GrantCommon Stock | 25,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-033606 · wk-form4_1778531958.xml · nonDerivative · entry 1 Murthy Mala · CIK 0001780955 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,479 F1 · kind: Reflects a grant of restricted stock units that vests on May 07, 2027. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:39 UTC |
Dingemans SimonDirector
|
GrantCommon Stock | 25,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-033604 · wk-form4_1778531942.xml · nonDerivative · entry 1 Dingemans Simon · CIK 0002104604 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,495 F1 · kind: Reflects a grant of restricted stock units that vests on May 7, 2027. Read SEC document |
| May 01, 2026 Filed May 5, 2026 23:44 UTC |
Dingemans SimonDirector
|
PurchaseCommon Stock | 25,000 | $8.14 | $203,500.00 |
DisclosureSEC source: 0001628280-26-030826 · wk-form4_1778024646.xml · nonDerivative · entry 1 Dingemans Simon · CIK 0002104604 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 25,000 Read SEC document |
| May 01, 2026 Filed May 5, 2026 23:40 UTC |
Brellier LudovicEVP, Bioscience & Medtech
|
GrantStock Options (Right to Buy) · Derivative | 246,002 | $0.00 Strike: $8.76 | $0.00 |
DisclosureSEC source: 0001628280-26-030825 · wk-form4_1778024423.xml · derivative · entry 2 Brellier Ludovic · CIK 0002132959 · EVP, Bioscience & Medtech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,002 Underlying: Common Stock · 246,002 shares Expires 2036-05-01 F2 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal annual installments beginning on May 1, 2027. Read SEC document |
| May 01, 2026 Filed May 5, 2026 23:40 UTC |
Brellier LudovicEVP, Bioscience & Medtech
|
GrantCommon Stock | 146,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-030825 · wk-form4_1778024423.xml · nonDerivative · entry 1 Brellier Ludovic · CIK 0002132959 · EVP, Bioscience & Medtech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,566 F1 · kind: Reflects a grant of restricted stock units that vest in three equal annual installments beginning on May 1, 2027. Read SEC document |
| April 03, 2026 Filed Apr 6, 2026 21:09 UTC |
Eck Steven WSVP & Chief Accounting Officer
|
GrantCommon Stock | 31,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023934 · wk-form4_1775509768.xml · nonDerivative · entry 1 Eck Steven W · CIK 0001748813 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,978 F1 · kind: Reflects a grant of restricted stock units that vest in three equal annual installments beginning on April 3, 2027. Read SEC document |
| March 10, 2026 Filed Mar 11, 2026 21:10 UTC |
MEHRA SANJEEV KDirector
|
PurchaseCommon Stock | 125,000 | $8.01 | $1,001,250.00 |
DisclosureSEC source: 0001628280-26-016904 · wk-form4_1773263425.xml · nonDerivative · entry 1 MEHRA SANJEEV K · CIK 0001029623 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By limited liability company Disclosed balance after: 475,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $7.98 to $8.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. F2 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:28 UTC |
Hankamer BrittanyEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 359 | $9.11 | $3,270.49 |
DisclosureSEC source: 0001628280-26-011811 · wk-form4_1772058478.xml · nonDerivative · entry 2 Hankamer Brittany · CIK 0001990909 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,045 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:27 UTC |
Eck Steven WSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 452 | $9.11 | $4,117.72 |
DisclosureSEC source: 0001628280-26-011808 · wk-form4_1772058460.xml · nonDerivative · entry 2 Eck Steven W · CIK 0001748813 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,333 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:28 UTC |
Hankamer BrittanyEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 1,324 | $8.89 | $11,770.36 |
DisclosureSEC source: 0001628280-26-011811 · wk-form4_1772058478.xml · nonDerivative · entry 1 Hankamer Brittany · CIK 0001990909 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,404 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 17:27 UTC |
Jones R. BrentEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 2,805 | $8.89 | $24,936.45 |
DisclosureSEC source: 0001628280-26-011810 · wk-form4_1772058472.xml · nonDerivative · entry 1 Jones R. Brent · CIK 0001588275 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 419,782 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:28 UTC |
Sokenu ClaudiusEVP, Chief Legal & Compliance
|
Tax withholdingCommon Stock | 2,376 | $8.89 | $21,122.64 |
DisclosureSEC source: 0001628280-26-011812 · wk-form4_1772058483.xml · nonDerivative · entry 1 Sokenu Claudius · CIK 0001926784 · EVP, Chief Legal & Compliance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,429 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:27 UTC |
Gourdier BenoitEVP, Bioscience & Medtech
|
Tax withholdingCommon Stock | 3,029 | $8.89 | $26,927.81 |
DisclosureSEC source: 0001628280-26-011809 · wk-form4_1772058466.xml · nonDerivative · entry 1 Gourdier Benoit · CIK 0001995333 · EVP, Bioscience & Medtech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 362,859 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:27 UTC |
Eck Steven WSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 2,017 | $8.89 | $17,931.13 |
DisclosureSEC source: 0001628280-26-011808 · wk-form4_1772058460.xml · nonDerivative · entry 1 Eck Steven W · CIK 0001748813 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,785 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 01:53 UTC |
Hankamer BrittanyEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 1,453 | $9.03 | $13,120.59 |
DisclosureSEC source: 0001628280-26-010833 · wk-form4_1771898036.xml · nonDerivative · entry 2 Hankamer Brittany · CIK 0001990909 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,728 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 20:53 UTC |
Jones R. BrentEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 9,506 | $9.03 | $85,839.18 |
DisclosureSEC source: 0001628280-26-010825 · wk-form4_1771897989.xml · nonDerivative · entry 2 Jones R. Brent · CIK 0001588275 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 422,587 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 01:53 UTC |
Eck Steven WSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 2,125 | $9.03 | $19,188.75 |
DisclosureSEC source: 0001628280-26-010830 · wk-form4_1771898019.xml · nonDerivative · entry 2 Eck Steven W · CIK 0001748813 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,802 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 01:53 UTC |
Walker CoreyPresident, VWR Dist. & Servs.
|
Tax withholdingCommon Stock | 4,963 | $9.03 | $44,815.89 |
DisclosureSEC source: 0001628280-26-010828 · wk-form4_1771898007.xml · nonDerivative · entry 2 Walker Corey · CIK 0001776172 · President, VWR Dist. & Servs. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 387,545 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 01:53 UTC |
Sokenu ClaudiusEVP, Chief Legal & Compliance
|
Tax withholdingCommon Stock | 2,919 | $9.03 | $26,358.57 |
DisclosureSEC source: 0001628280-26-010827 · wk-form4_1771898001.xml · nonDerivative · entry 2 Sokenu Claudius · CIK 0001926784 · EVP, Chief Legal & Compliance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,805 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 01:53 UTC |
Gourdier BenoitEVP, Bioscience & Medtech
|
Tax withholdingCommon Stock | 4,160 | $9.03 | $37,564.80 |
DisclosureSEC source: 0001628280-26-010826 · wk-form4_1771897995.xml · nonDerivative · entry 2 Gourdier Benoit · CIK 0001995333 · EVP, Bioscience & Medtech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,888 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:53 UTC |
Blenn MaryEVP, Chief Operating Officer
|
GrantStock Options (Right to Buy) · Derivative | 1,041,766 | $0.00 Strike: $11.05 | $0.00 |
DisclosureSEC source: 0001628280-26-010831 · wk-form4_1771898024.xml · derivative · entry 2 Blenn Mary · CIK 0002095866 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,041,766 Underlying: Common Stock · 1,041,766 shares Expires 2036-02-19 F2 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:53 UTC |
Blenn MaryEVP, Chief Operating Officer
|
GrantCommon Stock | 235,993 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-010831 · wk-form4_1771898024.xml · nonDerivative · entry 1 Blenn Mary · CIK 0002095866 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,384 F1 · kind: Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC |
Hankamer BrittanyEVP, Chief HR Officer
|
GrantStock Options (Right to Buy) · Derivative | 317,310 | $0.00 Strike: $11.05 | $0.00 |
DisclosureSEC source: 0001628280-26-010833 · wk-form4_1771898036.xml · derivative · entry 3 Hankamer Brittany · CIK 0001990909 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,310 Underlying: Common Stock · 317,310 shares Expires 2036-02-19 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC |
Hankamer BrittanyEVP, Chief HR Officer
|
GrantCommon Stock | 80,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-010833 · wk-form4_1771898036.xml · nonDerivative · entry 1 Hankamer Brittany · CIK 0001990909 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,181 F1 · kind: Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC |
LUCIER GREGORY TDirector
|
PurchaseCommon Stock | 50,000 | $9.16 | $458,000.00 |
DisclosureSEC source: 0001628280-26-010832 · wk-form4_1771898030.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By a Trust Disclosed balance after: 50,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $9.06 to $9.25, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. F2 · balance_after: By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:53 UTC |
Jones R. BrentEVP, Chief Financial Officer
|
GrantStock Options (Right to Buy) · Derivative | 634,617 | $0.00 Strike: $11.05 | $0.00 |
DisclosureSEC source: 0001628280-26-010825 · wk-form4_1771897989.xml · derivative · entry 3 Jones R. Brent · CIK 0001588275 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 634,617 Underlying: Common Stock · 634,617 shares Expires 2036-02-19 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:53 UTC |
Jones R. BrentEVP, Chief Financial Officer
|
GrantCommon Stock | 161,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-010825 · wk-form4_1771897989.xml · nonDerivative · entry 1 Jones R. Brent · CIK 0001588275 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 432,093 F1 · kind: Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC |
Ligner EmmanuelDirector · President and CEO
|
GrantStock Options (Right to Buy) · Derivative | 1,903,847 | $0.00 Strike: $11.05 | $0.00 |
DisclosureSEC source: 0001628280-26-010829 · wk-form4_1771898013.xml · derivative · entry 2 Ligner Emmanuel · CIK 0002082879 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,903,847 Underlying: Common Stock · 1,903,847 shares Expires 2036-02-19 F2 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC |
Ligner EmmanuelDirector · President and CEO
|
GrantCommon Stock | 483,713 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-010829 · wk-form4_1771898013.xml · nonDerivative · entry 1 Ligner Emmanuel · CIK 0002082879 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 767,137 F1 · kind: Reflects a grant of restricted stock units that vest in three equal installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC |
Eck Steven WSVP & Chief Accounting Officer
|
GrantStock Options (Right to Buy) · Derivative | 43,230 | $0.00 Strike: $9.21 | $0.00 |
DisclosureSEC source: 0001628280-26-010830 · wk-form4_1771898019.xml · derivative · entry 3 Eck Steven W · CIK 0001748813 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,230 Underlying: Common Stock · 43,230 shares Expires 2036-02-19 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC |
Eck Steven WSVP & Chief Accounting Officer
|
GrantCommon Stock | 48,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-010830 · wk-form4_1771898019.xml · nonDerivative · entry 1 Eck Steven W · CIK 0001748813 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,927 F1 · kind: Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC |
Walker CoreyPresident, VWR Dist. & Servs.
|
GrantStock Options (Right to Buy) · Derivative | 634,617 | $0.00 Strike: $11.05 | $0.00 |
DisclosureSEC source: 0001628280-26-010828 · wk-form4_1771898007.xml · derivative · entry 3 Walker Corey · CIK 0001776172 · President, VWR Dist. & Servs. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 634,617 Underlying: Common Stock · 634,617 shares Expires 2036-02-19 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC |
Walker CoreyPresident, VWR Dist. & Servs.
|
GrantCommon Stock | 161,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-010828 · wk-form4_1771898007.xml · nonDerivative · entry 1 Walker Corey · CIK 0001776172 · President, VWR Dist. & Servs. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,508 F1 · kind: Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC |
Sokenu ClaudiusEVP, Chief Legal & Compliance
|
GrantStock Options (Right to Buy) · Derivative | 317,310 | $0.00 Strike: $11.05 | $0.00 |
DisclosureSEC source: 0001628280-26-010827 · wk-form4_1771898001.xml · derivative · entry 3 Sokenu Claudius · CIK 0001926784 · EVP, Chief Legal & Compliance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,310 Underlying: Common Stock · 317,310 shares Expires 2036-02-19 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC |
Sokenu ClaudiusEVP, Chief Legal & Compliance
|
GrantCommon Stock | 80,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-010827 · wk-form4_1771898001.xml · nonDerivative · entry 1 Sokenu Claudius · CIK 0001926784 · EVP, Chief Legal & Compliance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,724 F1 · kind: Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC |
Gourdier BenoitEVP, Bioscience & Medtech
|
GrantStock Options (Right to Buy) · Derivative | 528,848 | $0.00 Strike: $11.05 | $0.00 |
DisclosureSEC source: 0001628280-26-010826 · wk-form4_1771897995.xml · derivative · entry 3 Gourdier Benoit · CIK 0001995333 · EVP, Bioscience & Medtech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 528,848 Underlying: Common Stock · 528,848 shares Expires 2036-02-19 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.